These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 23835634

  • 1. Effects of acetyl-DL-leucine in patients with cerebellar ataxia: a case series.
    Strupp M, Teufel J, Habs M, Feuerecker R, Muth C, van de Warrenburg BP, Klopstock T, Feil K.
    J Neurol; 2013 Oct; 260(10):2556-61. PubMed ID: 23835634
    [Abstract] [Full Text] [Related]

  • 2. Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
    Feil K, Adrion C, Teufel J, Bösch S, Claassen J, Giordano I, Hengel H, Jacobi H, Klockgether T, Klopstock T, Nachbauer W, Schöls L, Stendel C, Uslar E, van de Warrenburg B, Berger I, Naumann I, Bayer O, Müller HH, Mansmann U, Strupp M.
    BMC Neurol; 2017 Jan 10; 17(1):7. PubMed ID: 28068987
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of N-acetyl-L-leucine in patients with ataxia telangiectasia: A randomized, double-blind, placebo-controlled, crossover clinical trial.
    Beyraghi-Tousi M, Sahebkar A, Houra M, Sarvghadi P, Jamialahmadi T, Bagheri R, Tavallaie S, Gumpricht E, Saberi-Karimian M.
    Eur J Paediatr Neurol; 2024 May 10; 50():57-63. PubMed ID: 38669738
    [Abstract] [Full Text] [Related]

  • 4. Safety and Efficacy of Acetyl-DL-Leucine in Certain Types of Cerebellar Ataxia: The ALCAT Randomized Clinical Crossover Trial.
    Feil K, Adrion C, Boesch S, Doss S, Giordano I, Hengel H, Jacobi H, Klockgether T, Klopstock T, Nachbauer W, Schöls L, Steiner KM, Stendel C, Timmann D, Naumann I, Mansmann U, Strupp M, ALCAT Study Group.
    JAMA Netw Open; 2021 Dec 01; 4(12):e2135841. PubMed ID: 34905009
    [Abstract] [Full Text] [Related]

  • 5. Acetyl-dl-leucine in Niemann-Pick type C: A case series.
    Bremova T, Malinová V, Amraoui Y, Mengel E, Reinke J, Kolníková M, Strupp M.
    Neurology; 2015 Oct 20; 85(16):1368-75. PubMed ID: 26400580
    [Abstract] [Full Text] [Related]

  • 6. The Effect of N-Acetyl-DL-Leucine on Neurological Symptoms in a Patient with Ataxia-Telangiectasia: a Case Study.
    Saberi-Karimian M, Beyraghi-Tousi M, Mirzadeh M, Gumpricht E, Sahebkar A.
    Cerebellum; 2023 Feb 20; 22(1):96-101. PubMed ID: 35128617
    [Abstract] [Full Text] [Related]

  • 7. Aminopyridines and Acetyl-DL-leucine: New Therapies in Cerebellar Disorders.
    Kalla R, Strupp M.
    Curr Neuropharmacol; 2019 Feb 20; 17(1):7-13. PubMed ID: 30182858
    [Abstract] [Full Text] [Related]

  • 8. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment.
    du Montcel ST, Charles P, Ribai P, Goizet C, Le Bayon A, Labauge P, Guyant-Maréchal L, Forlani S, Jauffret C, Vandenberghe N, N'guyen K, Le Ber I, Devos D, Vincitorio CM, Manto MU, Tison F, Hannequin D, Ruberg M, Brice A, Durr A.
    Brain; 2008 May 20; 131(Pt 5):1352-61. PubMed ID: 18378516
    [Abstract] [Full Text] [Related]

  • 9. Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia-a case series.
    Schniepp R, Strupp M, Wuehr M, Jahn K, Dieterich M, Brandt T, Feil K.
    Cerebellum Ataxias; 2016 May 20; 3():8. PubMed ID: 27073690
    [Abstract] [Full Text] [Related]

  • 10. The Effects of N-Acetyl-L-Leucine on the Improvement of Symptoms in a Patient with Multiple Sulfatase Deficiency.
    Saberi-Karimian M, Houra M, Jamialahmadi T, Sarvghadi P, Nikbaf M, Akhlaghi S, Sahebkar A.
    Cerebellum; 2023 Dec 20; 22(6):1250-1256. PubMed ID: 36482027
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Reliability of the Japanese version of the Scale for the Assessment and Rating of Ataxia (SARA)].
    Sato K, Yabe I, Soma H, Yasui K, Ito M, Shimohata T, Onodera O, Nakashima K, Sobue G, Nishizawa M, Sasaki H.
    Brain Nerve; 2009 May 20; 61(5):591-5. PubMed ID: 19514520
    [Abstract] [Full Text] [Related]

  • 14. Effects of Acetyl-DL-Leucine on Ataxia and Downbeat-Nystagmus in Six Patients With Ataxia Telangiectasia.
    Brueggemann A, Bicvic A, Goeldlin M, Kalla R, Kerkeni H, Mantokoudis G, Abegg M, Kolníková M, Mohaupt M, Bremova-Ertl T.
    J Child Neurol; 2022 Jan 20; 37(1):20-27. PubMed ID: 34620022
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A comprehensive scheme for the objective upper body assessments of subjects with cerebellar ataxia.
    Tran H, Nguyen KD, Pathirana PN, Horne MK, Power L, Szmulewicz DJ.
    J Neuroeng Rehabil; 2020 Dec 04; 17(1):162. PubMed ID: 33276783
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of N-acetyl-L-leucine in Niemann-Pick disease type C.
    Bremova-Ertl T, Claassen J, Foltan T, Gascon-Bayarri J, Gissen P, Hahn A, Hassan A, Hennig A, Jones SA, Kolnikova M, Martakis K, Raethjen J, Ramaswami U, Sharma R, Schneider SA.
    J Neurol; 2022 Mar 04; 269(3):1651-1662. PubMed ID: 34387740
    [Abstract] [Full Text] [Related]

  • 19. Acetyl-DL-leucine in cerebellar ataxia ([18F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks?
    Becker-Bense S, Kaiser L, Becker R, Feil K, Muth C, Albert NL, Unterrainer M, Bartenstein P, Strupp M, Dieterich M.
    J Neurol; 2023 Jan 04; 270(1):44-56. PubMed ID: 35876876
    [Abstract] [Full Text] [Related]

  • 20. Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings.
    Jacobi H, Hauser TK, Giunti P, Globas C, Bauer P, Schmitz-Hübsch T, Baliko L, Filla A, Mariotti C, Rakowicz M, Charles P, Ribai P, Szymanski S, Infante J, van de Warrenburg BP, Dürr A, Timmann D, Boesch S, Fancellu R, Rola R, Depondt C, Schöls L, Zdzienicka E, Kang JS, Ratzka S, Kremer B, Stephenson DA, Melegh B, Pandolfo M, Tezenas du Montcel S, Borkert J, Schulz JB, Klockgether T.
    Cerebellum; 2012 Mar 04; 11(1):155-66. PubMed ID: 21701895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.